HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
4th Edition of
International Ophthalmology Conference
March 23-25, 2026 | Singapore
Vision Rehabilitation
Vision Rehabilitation
Rehabilitation (literally, "becoming able again") aids patients in regaining physical, social, emotional, and spiritual independence, as well as improving their quality of life. Rehabilitation aims to enhance function and independence via adaptation rather than undoing or reversing the cause of harm. A medical rehabilitation to improve vision or low vision is known as vision rehabilitation (also known as vision rehab). In other words, it is the process of regaining functional capacity and increasing quality of life and independence in someone who has lost their vision due to disease or injury. Low vision rehabilitation allows optometrists to help their patients improve their function, independence, and general health.
- Clinical Studies and Treatments
- Neurological Approach
- Chemical Treatments
- Physical Approach
Committee Members
Shadrokh Nabili
University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom
Anna Maria Bassi
University of Genoa, Italy
Tim Jackson
King’s College London, United Kingdom IOC 2026 Speakers
Agnieszka Rosa
Orticus Center for the Treatment of Strabismus and Vision Disorders, Poland
Arrane Selvamogan
Leicestershire Partnership NHS Trust, United Kingdom
Raheel Faiz
UHCW, United Kingdom
Shayaan Kaleem
University of Toronto, CanadaSubmit your abstract Today
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : From visual cortex to computer vision: The historical convergence and future frontier of artificial intelligence and ophthalmology
Sreedhar Potarazu, American Eye Care Center, maryland, United States
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Targeting immunological pathways in Behcet's uveitis
Hashim Butt, Bolton Royal Hospital, United Kingdom
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom